RL
Rudy Li Chardan Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
Past Year
41%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $30 |
32%
upside
| 4 | +19% |
0
%
| 2 Jan ‘26 5 days ago |
|
|
|
Buy
Maintained
| $80 |
10%
downside
| 3 | +57% |
0
%
| 2 Jan ‘26 5 days ago |
|
|
|
Buy
Maintained
| $330 |
17%
upside
| 3 | +106% |
0
%
| 17 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $55 |
33%
upside
| 4 | +4.2% |
0
%
| 7 Oct ‘25 3 months ago |
|
|
|
Buy
Initiated
| $3 |
355%
upside
| 1 | -34% |
0
%
| 29 Sep ‘25 3 months ago |
|
|
|
Buy
Initiated
| $15 |
3%
downside
| 1 | +282% |
0
%
| 29 Sep ‘25 3 months ago |
|
|
|
Buy
Initiated
| $2 |
503%
upside
| 1 | +9.5% |
0
%
| 29 Sep ‘25 3 months ago |
|
|
|
Buy
Maintained
| $18 |
97%
upside
| 5 | -5.4% |
0
%
| 28 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $24 |
35%
downside
| 3 | +68% |
0
%
| 13 Aug ‘25 4 months ago |
|
|
|
Buy
Maintained
| $20 |
47%
upside
| 2 | +45% |
0
%
| 1 Aug ‘25 5 months ago |
|